Ann Arbor Weather:
Friday October 20, 2017
Follow us: facebook twitter RSS feed
Print Comment E-mail

Breakthrough

 

continued

"Our socks were just knocked off. You know, couldn't believe it."

Many chemicals will destroy tumors in mice, but only at doses so high that they cripple or kill the host mice. These mice appeared fine. And though it's much easier to cure cancer in mice than in humans, the impeccable science behind this drug made it especially promising.

The mouse experiments took place in 2001, after six years of grueling work by a team at the massive Parke-Davis pharmaceutical research complex. (Pfizer took over Parke-Davis, and the labs, in 2000.) After making hundreds of compounds and conducting thousands of experiments, chemists under the direction of project co-leader Peter Toogood had synthesized the drug, known internally as PD-0332991.

At the time, Fry and Toogood could not have imagined that it would take more than a dozen years to bring the promising drug to market. (It's still not quite there.) Pfizer shut down the local labs six years ago. But like an echo that grows louder with time, its products are still making an impact.

Bookmark and Share
previous  ·  1 l 2 l 3 l 4 l 5 l 6 l 7 l 8  ·  next page
all on one page
read more stories here -> Marketplace  l  Culture  l  Community  l  News

You might also like:

Beethoven for Refugees
"Ode to Joy" at Hill
Davi Napoleon
Nightspots: Arbor Brewing Company Microbrewery
Photo: Gallup Park
Emergency Services
Delis, Sandwiches and Subs Restaurants
Today's Events
The Shur Mural Project
I Spy: August 2017
Sally Bjork
In the Rough at the AACC
While lawyers fight over its future, a suburban golf course goes back to nature.
Cynthia Furlong Reynolds
Sixteen Hands
The Emerson and Calidore Quartets
arwulf arwulf
Notes from the Field
Botanizing on Broadway
Irena Barbara Nagler
Regent Hotel
String Bass lessons by Steven Sigurdson
A visitor's guide to Ann Arbor